What's dying. What's changing. What's being born.
The supplement category is reshuffling. Here's what brand leaders need to know about where the market is headed.
The 2026 reshuffling
Every year, we publish what we're seeing across the 30+ supplement brands we research and analyze. This isn't trend forecasting from a research desk. It's pattern recognition from studying the operations of brands doing $1M-$100M in supplement revenue.
2026 is a reshuffling year. The playbooks that worked in 2022-2024 are showing diminishing returns. The brands that are pulling ahead are the ones rebuilding their stack around retention, education, and clinical credibility - not just acquisition efficiency. Here's the breakdown.
What's Dying
Hero-SKU brands without education
The era of launching a single product with a beautiful brand and scaling on Meta is over. Brands that can't explain why their product works - with clinical specificity, not marketing copy - are losing ground to brands that can. AG1 educated the market into needing greens. If you can't do the same for your category, you're renting attention you can't convert.
Homepage-as-landing-page
The 2020-2023 playbook of sending all traffic to a long-form homepage that functions as a sales page is dying. Returning visitors, referral traffic, and organic searchers need different experiences. Brands still running a single-page funnel are losing consideration-stage visitors who want to browse, learn, and compare before buying.
Pure brand ads without direct response mechanics
Brand awareness campaigns that don't have a measurable conversion path are getting cut. Not because brand doesn't matter - it does. But because CFOs at $5M-$50M supplement brands can't justify spend that doesn't have an attributable return within 90 days. The brands winning are building brand through direct response, not alongside it.
Forced subscriptions without risk reversal
Subscribe-and-save with no money-back guarantee, no skip option, and no easy cancel is dying. Consumers have been burned too many times. The brands that are growing subscription penetration are the ones offering 90-day guarantees, one-click skip, and transparent cancel flows. The irony: more flexibility drives more commitment.
Complex loyalty programs
Points systems, tier structures, and gamified loyalty programs are being quietly killed by the brands that built them. The data is clear: in supplements, loyalty programs don't drive retention - product efficacy and habit formation do. Points programs add technical debt and customer confusion without moving the needle on repeat purchase rates.
Welcome emails with no offer
Sending a welcome email that says 'Thanks for signing up!' without a specific offer, educational content, or next action is a wasted touchpoint. In supplements, the welcome flow is the single highest-leverage email sequence. Brands still sending generic welcome emails are losing 30-40% of potential conversion from their warmest leads.
What's Changing
90-day subscription default is becoming standard
AG1 proved it. Seed normalized it. Now every serious supplement brand is testing 90-day default subscriptions. The economics are compelling: 90-day defaults increase LTV by 40-60% compared to monthly because they push the customer past the habit-formation threshold. Expect this to be industry standard by end of 2026.
Scientific advisory boards over celebrity endorsements
Celebrity partnerships aren't dead, but they're being supplemented (pun intended) by named scientific advisory boards. Seed, Momentous, and Ritual all feature named researchers with published credentials. The shift: consumers still want authority figures, but they want credentialed authority over famous authority. Both is even better.
Named competitor comparison tables
Two years ago, comparing yourself to competitors on your own PDP felt risky. Now it's becoming a conversion requirement. Momentous does it. AG1 does it implicitly. The reason: if you don't control the comparison, Google and Reddit will. Better to own the narrative on your turf with a table that's designed to make you win.
Clinical RCTs replacing ingredient-level claims
The bar is rising from 'contains clinically studied ingredients' to 'our product has been clinically studied.' Ritual published RCTs on their multivitamin. Seed publishes on DS-01. This is expensive - $500K-$2M per trial - but it's becoming the price of admission for premium positioning. Brands that can't point to product-level data will be positioned as commodity.
Creator volume over production polish
The shift from 3 highly-produced influencer campaigns to 200+ raw creator integrations is accelerating. AG1's strategy of saturating mid-tier podcasts and YouTube channels proved that frequency beats polish. The new media buying equation: 50 creators at $2K each outperforms 2 creators at $50K each. Volume creates omnipresence.
What's Being Born
Advertorials on owned domains
AG1 pioneered this. Now every sophisticated supplement brand is building editorial-style landing pages on owned domains that look and read like third-party content. These aren't deceptive - they're clearly branded. But the format (long-form editorial with embedded CTAs) converts 2-4x better than traditional landing pages for cold traffic because it matches the content consumption pattern of the reader.
Community-as-retention
LMNT's Facebook group. Seed's 'SeedUniversity.' Momentous's protocol communities. The insight: email-based retention has a ceiling. Community-based retention creates social switching costs that email can't replicate. When you're part of a group that uses the product, cancelling means leaving the group. That's a fundamentally different retention mechanic than a 10% discount.
Quiz funnels as the default entry point
Hiya, Care/of, and Persona proved that quiz-to-subscription converts at 2-3x standard PDP conversion rates. The quiz does three things simultaneously: it qualifies the visitor, personalizes the recommendation, and creates investment (sunk cost of completing the quiz). By 2027, every multi-SKU supplement brand will have a quiz as their primary conversion path.
Post-purchase education sequences
The 8-email post-purchase education sequence is emerging as a category standard. AG1's version ties ingredients to outcomes with specific timelines. Seed's explains the microbiome. The pattern: education after purchase doesn't just reduce refund rates - it extends subscription duration by 2-3 months because it builds belief in the product's mechanism before the customer can experience results.
GLP-1 companion products - everything
The GLP-1 wave (Ozempic, Wegovy, Mounjaro) is creating an entirely new supplement category: products designed to complement or manage GLP-1 side effects. Protein supplements for muscle preservation, electrolytes for hydration, probiotics for gut health, multivitamins for nutrient absorption. Every major supplement brand is either launching a GLP-1 companion line or losing share to brands that are. This is the biggest category creation event in supplements since protein powder went mainstream.
The deeper read
The three-column view above gives you the map. Below, let's dig into the three trends that will have the most material impact on supplement brand economics in 2026.
Hero-SKU brands without education infrastructure
The math has changed. In 2021, you could launch a single supplement SKU, build a beautiful brand, run Meta ads, and scale to $5M-$10M. CACs were $30-50, subscription economics were forgiving, and the market was growing fast enough to paper over retention problems.
In 2026, CACs for supplement brands on Meta are $65-120. That means your first-order contribution margin is negative for most brands. You need 3-4 months of subscription retention just to break even on acquisition. And hero-SKU brands without education - brands that can't explain why their product works with clinical specificity - are seeing month-2 retention rates of 45-55%. That means half your customers leave before you've recovered your acquisition cost.
The brands surviving with a single SKU are the ones that built education infrastructure around it. AG1 has more content about why greens matter than any competitor. Seed publishes actual research. The product is the commodity. The education is the moat.
GLP-1 companion products
By the end of 2026, an estimated 30-40 million Americans will be on GLP-1 medications. Every single one of them has specific supplementation needs: protein for muscle preservation (GLP-1s cause lean mass loss), electrolytes (dehydration is a common side effect), B vitamins (absorption is impaired), probiotics (GI side effects are near-universal).
This isn't a niche. It's the largest category-creation event in supplements since whey protein went mainstream in the 2000s. Brands like Momentous and LMNT are already positioning products for the GLP-1 audience. New brands are launching specifically for this cohort.
The opportunity for existing supplement brands is straightforward: reposition existing products (protein, electrolytes, multivitamins) for the GLP-1 use case with dedicated landing pages, specific dosing protocols, and content that speaks to the GLP-1 experience. You don't need new products. You need new positioning and new landing pages.
Creator volume over production polish
AG1's media strategy is the template. They don't work with 5 creators at $100K each. They work with 200+ creators at $2K-$10K each. The result: omnipresence. Every podcast listener, every YouTube viewer in the health and productivity space has encountered AG1. That's not luck - it's a volume strategy executed with discipline.
The implication for supplement brands in 2026: reallocate budget from high-production influencer campaigns to high-volume creator programs. You want 50 authentic integrations, not 2 polished endorsements. The algorithm rewards consistency and variety. Your audience trusts the creator they follow, not the production quality of the ad. Invest accordingly.
What this means if you're building a supplement brand in 2026
If you're reading the "dying" column and seeing your current playbook, don't panic. The shift isn't happening overnight - it's happening over 18-24 months. You have time to adapt. But you need to start now.
Here's our priority stack for supplement brands heading into the back half of 2026:
- Build your education infrastructure. If you can't explain why your product works with clinical specificity in a 2,000-word advertorial, you're not ready to scale.
- Move to a 90-day default subscription. The data is overwhelming. Monthly subscriptions are a retention liability.
- Launch a quiz funnel. If you have more than 3 SKUs, a quiz should be your primary conversion path, not a PDP.
- Build your post-purchase education sequence. 8 emails, tied to specific ingredients, outcomes, and timelines. This is the highest-leverage retention investment you can make.
- Evaluate GLP-1 positioning. If you sell protein, electrolytes, or multivitamins, you're already in the GLP-1 companion category. You just need the landing page.
The brands that will win in 2026-2027 aren't the ones with the best product or the biggest ad budget. They're the ones that built the systems - education, retention, community - while everyone else was still optimizing CPMs.
Ready to put these frameworks to work?
MediaSeize builds the growth systems described in this report for CPG, supplement, and DTC brands. Tell us about your brand and we'll follow up within 24 hours with specific thoughts on where to start.